AccuStem Sciences Limited

$0.13-7.14%($-0.01)
TickerSpark Score
46/100
Weak
100
Valuation
20
Profitability
40
Growth
40
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACMSY research report →

52-Week Range22% of range
Low $0.01
Current $0.13
High $0.56

Companywww.accustem.com

Accustem Sciences Limited engages in the genomic signature-based assay business for the prognosis of early and late recurrence of ER+/HER2 breast cancer in early stage breast cancer patients. The company was incorporated in 2020 and is based in London, the United Kingdom.

IPO
2021
HQ
London, GB

Price Chart

-18.75% · this period
$0.25$0.17$0.10Jan 03Feb 10Apr 24

Valuation

Market Cap
$0
P/E
-0.00
P/S
0.00
P/B
-0.54
EV/EBITDA
0.00
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
205.94%
ROIC
45350.84%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-1,756,096,000 · -116584.12%
EPS
$-0.12 · 7.69%
Op Income
$-1,756,096,000
FCF YoY
-127957.90%

Performance & Tape

52W High
$0.56
52W Low
$0.01
50D MA
$0.14
200D MA
$0.23
Beta
0.00
Avg Volume
18.16K

Get TickerSpark's AI analysis on ACMSY

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Jun 13, 25CERRONE GABRIELE Mbuy400
Jun 13, 25CERRONE GABRIELE Mbuy2,000
Jun 12, 25CERRONE GABRIELE Mbuy8,991
Jun 11, 25CERRONE GABRIELE Mbuy28,205
Apr 9, 25CERRONE GABRIELE Mbuy3,000
Apr 8, 25CERRONE GABRIELE Mbuy35,000
Apr 7, 25CERRONE GABRIELE Mbuy35,000
Apr 7, 25CERRONE GABRIELE Mbuy17,802
Mar 18, 25CERRONE GABRIELE Mbuy100,000
Dec 31, 24CERRONE GABRIELE Mbuy100,000

Our ACMSY Coverage

We haven't published any research on ACMSY yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate ACMSY Report →